<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04995848</url>
  </required_header>
  <id_info>
    <org_study_id>N-20200094</org_study_id>
    <nct_id>NCT04995848</nct_id>
  </id_info>
  <brief_title>Telepalliation - Digital Platform for Patients in Palliation and Their Relatives</brief_title>
  <official_title>Elepalliation - Digital Platform for Patienter i Palliation og Deres pårørende</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aalborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Palliative Team,Hospital of South West Jutland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Center for Innovative Medical Technologies (CIMT), Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Danish Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laboratory of Welfare Technology, Department of Health Science and Technology, Aalborg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aalborg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project has focus on patients in palliation testing a digital platform TelePal.dk.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the RCT study is to:&#xD;
&#xD;
      • Test, implement, and evaluate a telepalliation program for patients receiving palliative&#xD;
      care (cancer, heart failure (HF), COPD, and motor neuron disease) from a clinical,&#xD;
      psychosocial, inter-organizational, and health economic perspective.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 26, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Mixed method randomised control trial</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Quality of life</measure>
    <time_frame>At baseline, week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, and 26</time_frame>
    <description>Measured by the European Organization for Research and Treatment of Cancer, questionnaire regarding quality of life in palliative cancer care patients (EORTC QLQ-C15-PAL).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in medicine</measure>
    <time_frame>At enrolment and week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, and 26</time_frame>
    <description>Information on medicine for both groups will be collected at enrolment and every week from the electronic patient record (EPR). Changes in medicine over time will be analyzed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in feeling of security</measure>
    <time_frame>At baseline, twice every week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, and 26</time_frame>
    <description>Measured on a likert scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Experiences of pain</measure>
    <time_frame>At baseline, week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, and 26</time_frame>
    <description>Numerical Rating Scale (NRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Experience of pain (brief)</measure>
    <time_frame>At baseline, week 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, and 26</time_frame>
    <description>Brief Pain Inventory, short form (BPI-sf)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Experiences of patients on the actual use of the TelePal.dk platform and their experiences of being a part of a telepalliation program</measure>
    <time_frame>Week 4</time_frame>
    <description>Qualitative interviews</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Experiences of relatives on the actual use of the TelePal.dk platform and their experiences of being a part of a telepalliation program</measure>
    <time_frame>Week 4 and 3 months</time_frame>
    <description>Qualitative interviews</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Experiences of health care professionals on the actual use of the TelePal.dk platform and their experiences of being a part of a telepalliation program</measure>
    <time_frame>6 months and 12 months</time_frame>
    <description>Qualitative interviews</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceptions on usability of a cross-sector communication platform and telerehabilitation program by patients, relatives and health care professionals</measure>
    <time_frame>12 months</time_frame>
    <description>Qualitative interviews</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Observations on usability of a cross-sector communication platform and telerehabilitation program by patients, relatives and health care professionals</measure>
    <time_frame>12 months</time_frame>
    <description>Observations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health related quality of life</measure>
    <time_frame>week 1 and week 4</time_frame>
    <description>Measured by EQ-5D Health Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of healthcare services</measure>
    <time_frame>24 months</time_frame>
    <description>Cost-effectiveness analysis ((number of phone/video calls, equipment, driving, personal use in palliative care (video and home visits), visits to general practitioner and outpatient clinic, hospitalizations, readmissions and length of stay, visits from palliative team))</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">182</enrollment>
  <condition>Cancer</condition>
  <condition>Heart Failure</condition>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Neurological Diseases</condition>
  <arm_group>
    <arm_group_label>Telepalliation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention group will participate in the telepalliation program. The patients will lent a tablet during the RCT study to access the TelePal.dk platform an video consultations. The patients will participate from the time they are referred to palliative care, and are enrolled in the telepalliation program for up to six months or until:&#xD;
They stop being followed by the Palliative Team due to lack of symptoms&#xD;
They are diagnosed with delirium based upon clinical guidelines and the Confusion Assessment Method (CAM). The assessment of delirium will be done by either:&#xD;
The project nurse or the clinical responsible doctor at the patients' home OR&#xD;
A district nurse under video supervision by the project nurse or the clinical responsible doctor&#xD;
Death of the patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional palliation program</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control group will follow a conventional palliation program. The patients will participate from the time they are referred to palliative care, and are enrolled in the telepalliation program for up to six months or until:&#xD;
They stop being followed by the Palliative Team due to lack of symptoms&#xD;
They are diagnosed with delirium based upon clinical guidelines and the Confusion Assessment Method (CAM). The assessment of delirium will be done by either:&#xD;
The project nurse or the clinical responsible doctor at the patients' home OR&#xD;
A district nurse under video supervision by the project nurse or the clinical responsible doctor&#xD;
Death of the patient</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telepalliation</intervention_name>
    <description>Telepalliation platform Telepal.dk</description>
    <arm_group_label>Telepalliation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Over 18 years&#xD;
&#xD;
          -  Live in Esbjerg, Varde, Billund, Fanø or Vejen Municipality&#xD;
&#xD;
          -  Cancer, heart failure, chronic obstructive pulmonary disease (COPD), and motor neuron&#xD;
             disease (neurological diseases) referred to the Palliation Team at Southwest Jutland&#xD;
             Hospital&#xD;
&#xD;
          -  Basic computer skills or a relative who has basic computer skills&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Delirium at enrolment based on CAM score&#xD;
&#xD;
          -  Active psychiatric history (as noted in the medical record) other than depression or&#xD;
             anxiety related to the main diagnosis referred to palliative care&#xD;
&#xD;
          -  Lack of ability to cooperate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Birthe Dinesen, MSc, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aalborg University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jarl Voss Andersen Sigaard, MD</last_name>
    <role>Study Director</role>
    <affiliation>Palliative Team, South West Jutland Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Birthe Dinesen, MSc, PhD</last_name>
    <phone>+4520515944</phone>
    <email>bid@hst.aau.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jarl Voss Andersen Sigaard, MD</last_name>
    <email>Jarl.Sigaard@rsyd.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Palliative Team, South West Jutland Hospital</name>
      <address>
        <city>ESbjerg</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jarl Sigaard</last_name>
      <email>jarl.Sigaard@rsyd.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.labwelfaretech.com/en/</url>
    <description>Read more about the Laboratory for Welfare Technology - telehealth and telerehabilitation, Aalborg University</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>May 26, 2021</study_first_submitted>
  <study_first_submitted_qc>July 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2021</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aalborg University</investigator_affiliation>
    <investigator_full_name>Birthe Dinesen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Palliative care</keyword>
  <keyword>Palliation</keyword>
  <keyword>Platform</keyword>
  <keyword>Quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan for sharing protocol as we are applying for patent.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

